↓ Skip to main content

Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice

Overview of attention for article published in BMC Complementary Medicine and Therapies, September 2015
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users
video
1 YouTube creator

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice
Published in
BMC Complementary Medicine and Therapies, September 2015
DOI 10.1186/s12906-015-0832-z
Pubmed ID
Authors

Swee Keong Yeap, Nadiah Abu, Nurul Elyani Mohamad, Boon Kee Beh, Wan Yong Ho, Siamak Ebrahimi, Hamidah Mohd Yusof, Huynh Ky, Sheau Wei Tan, Noorjahan Banu Alitheen

Abstract

The progression of breast cancer is increasing at an alarming rate, particularly in western countries. Meanwhile, the lower incidence in Asian countries could be attributed to the heavy incorporation of green leaves vegetables or spices in their diets. Murraya koenigii (MK) or often times known as curry leaves are common spice used mostly in tropical countries. Anti-inflammatory and chemopreventive effects of MK aqueous extract on 4T1 breast cancer cell-challenged mice were evaluated. Herein, cytotoxic activity of MK was first tested on 4T1 cells in vitroby MTT assay. Then, in vivo chemopreventive study was conducted where mice were fed with extracts prior to and after inducing the tumor (inoculation). Tumor size was monitored post-4T1 inoculation. At the end of experiment, histopathology of tumor sections, T cell immunophenotyping, tumor nitric oxide level, serum cytokine level and qPCR analysis on expression of iNOS, iCAM, NF-kB and c-MYC were performed. MK reduced the tumors' size and lung metastasis aside from inhibited the viability of 4T1 cells in vitro. Furthermore, it decreased the level of nitric oxide and inflammation-related cytokines and genes, including iNOS, iCAM, NF-kB and c-MYC. The results propose that, MK managed to inhibit the progression of tumor via immunostimulatory effect and inflammatory reaction within the tumor samples. This suggests that MKconsumption could be a savior in the search of new chemopreventive agents.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 68 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 16%
Student > Bachelor 9 13%
Student > Ph. D. Student 6 9%
Lecturer > Senior Lecturer 3 4%
Researcher 3 4%
Other 8 12%
Unknown 28 41%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 10 15%
Agricultural and Biological Sciences 9 13%
Medicine and Dentistry 6 9%
Pharmacology, Toxicology and Pharmaceutical Science 5 7%
Chemistry 4 6%
Other 4 6%
Unknown 30 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2022.
All research outputs
#15,985,478
of 24,325,299 outputs
Outputs from BMC Complementary Medicine and Therapies
#1,893
of 3,821 outputs
Outputs of similar age
#152,336
of 271,654 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#43
of 89 outputs
Altmetric has tracked 24,325,299 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,821 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,654 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.